CME Medical announces collaboration with leading ultrasound company

27-May-2015

Launch of eZono 4000 represents a new era of imaging, needle guidance and education

CME Medical, the market leader in the specialist infusion pump field, has announced a partnership with eZono, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000.

The eZono 4000 represents a new era of imaging, needle guidance and education, using revolutionary technology to provide advanced functionality for procedural guidance, with the simplicity and reliability requested and required by clinicians. The eZono 4000 can be used for a wide range of applications and procedures in multiple clinical settings

CME Medical’s dedication to patient wellbeing, alongside its reputation for providing education, support, and training across the market makes the organisation an ideal partner for eZono. The Blackpool-based company champions innovative healthcare solutions and sees this as a natural extension to its existing portfolio in IV therapy.

The eZGuide FreePlane Navigation within the eZono 4000 is a unique and revolutionary needle guidance system technology that enables clinicians to easily target desired anatomy in or out of plane without any additional hardware or proprietary needles, thus reducing costs and improving efficiency and accuracy.

CME Medical is dedicated to educating existing and potential customers on the unique benefits of the eZono 4000 including:

• eZGuide FreePlane Navigation with Adaptive Needle Recognition: Proprietary needle guidance technology lets you know exactly where you are in relation to your target
• Precision: eZGuide’s technology allows precise needle placement from any plane
• Time Savings: eZGuide’s revolutionary needle guidance technology improves efficiency
• Customer Education: Cue Card onboard Education offers detailed step-by-step instructions, along with 3D anatomical illustrations, allowing clinicians to practice as they scan
• Clinical Outcomes: Improved accuracy means decreased complications and better outcomes
• Cost Savings: eZGuide requires no additional expensive hardware, proprietary needles or special gauges
• Increased patient comfort: Reduction of anxiety and pain
• Reduces multiple puncture attempts, thus, potentially reducing infection rates
• Reduced risk of infection from needle re-entry

John Carrington, managing director of CME Medical, said: “The eZono 4000 offers a unique new approach to the patient pathway, and we’re pleased to welcome it into the CME Medical product portfolio to complement our existing range.

This gold standard in care benefits both practitioner and patient, creating the safest and most-comfortable environment for these procedures. As a leader in the portable infusion sector, our existing customers already have exposure to ultrasound products, providing us with a great platform to start educating them about the benefits of the eZono 4000. ”

Tracey Byard, general manager at eZono, added: “With CME Medical’s reputation for providing expert training and advice to ensure its products are used safely and effectively, we know we are partnering with a company that shares the same values. Our training with the CME Medical team has already begun and we will continue to work together to increase existing product knowledge.

Companies

• CME Medical
• eZono